These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension. Penumatsa KC; Toksoz D; Warburton RR; Kharnaf M; Preston IR; Kapur NK; Khosla C; Hill NS; Fanburg BL Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L752-L762. PubMed ID: 28775095 [TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2 knockout mice are protected from bleomycin-induced lung fibrosis with preserved lung function and reduced metabolic derangements. Freeberg MAT; Thatcher TH; Camus SV; Huang L; Atkinson J; Narrow W; Haak J; Dylag AM; Cowart LA; Johnson TS; Sime PJ Physiol Rep; 2024 Jun; 12(12):e16012. PubMed ID: 38959068 [TBL] [Abstract][Full Text] [Related]
5. TG2 participates in pulmonary vascular remodelling by regulating the senescence of pulmonary artery smooth muscle cells. Zhang M; Li L; Zhang W; Li M; Yan G; Tang C Cell Signal; 2024 Sep; 121():111296. PubMed ID: 39009200 [TBL] [Abstract][Full Text] [Related]
6. Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice. DiRaimondo TR; Klöck C; Warburton R; Herrera Z; Penumatsa K; Toksoz D; Hill N; Khosla C; Fanburg B ACS Chem Biol; 2014 Jan; 9(1):266-75. PubMed ID: 24152195 [TBL] [Abstract][Full Text] [Related]
7. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. Oh K; Park HB; Byoun OJ; Shin DM; Jeong EM; Kim YW; Kim YS; Melino G; Kim IG; Lee DS J Exp Med; 2011 Aug; 208(8):1707-19. PubMed ID: 21746810 [TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 and its role in pulmonary fibrosis. Olsen KC; Sapinoro RE; Kottmann RM; Kulkarni AA; Iismaa SE; Johnson GV; Thatcher TH; Phipps RP; Sime PJ Am J Respir Crit Care Med; 2011 Sep; 184(6):699-707. PubMed ID: 21700912 [TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Popov Y; Sverdlov DY; Sharma AK; Bhaskar KR; Li S; Freitag TL; Lee J; Dieterich W; Melino G; Schuppan D Gastroenterology; 2011 May; 140(5):1642-52. PubMed ID: 21277850 [TBL] [Abstract][Full Text] [Related]
11. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001 [TBL] [Abstract][Full Text] [Related]
12. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer. Lee J; Yakubov B; Ivan C; Jones DR; Caperell-Grant A; Fishel M; Cardenas H; Matei D Neoplasia; 2016 Nov; 18(11):689-698. PubMed ID: 27792935 [TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis. Jeong EM; Son YH; Choi Y; Kim JH; Lee JH; Cho SY; Kim IG Exp Mol Med; 2016 Nov; 48(11):e267. PubMed ID: 27811936 [TBL] [Abstract][Full Text] [Related]
14. Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation. Penumatsa KC; Toksoz D; Warburton RR; Hilmer AJ; Liu T; Khosla C; Comhair SA; Fanburg BL Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L576-85. PubMed ID: 25128524 [TBL] [Abstract][Full Text] [Related]
15. Blocking TG2 attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting EMT. Wang K; Zu C; Zhang Y; Wang X; Huan X; Wang L Respir Physiol Neurobiol; 2020 May; 276():103402. PubMed ID: 32006666 [TBL] [Abstract][Full Text] [Related]
16. Nitrosylation of tissue transglutaminase enhances fibroblast migration and regulates MMP activation. Kurt-Celep İ; Nihan Kilinc A; Griffin M; Telci D Matrix Biol; 2022 Jan; 105():1-16. PubMed ID: 34763097 [TBL] [Abstract][Full Text] [Related]
17. Spatially Resolved Identification of Transglutaminase Substrates by Proteomics in Pulmonary Fibrosis. Takeuchi T; Tatsukawa H; Shinoda Y; Kuwata K; Nishiga M; Takahashi H; Hase N; Hitomi K Am J Respir Cell Mol Biol; 2021 Sep; 65(3):319-330. PubMed ID: 34264172 [TBL] [Abstract][Full Text] [Related]
18. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats. Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208 [TBL] [Abstract][Full Text] [Related]
19. Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension. Liu C; Luo R; Wang W; Peng Z; Johnson GVW; Kellems RE; Xia Y Am J Hypertens; 2019 Apr; 32(5):476-485. PubMed ID: 30715101 [TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase: a multifunctional and multisite regulator in health and disease. Yao Z; Fan Y; Lin L; Kellems RE; Xia Y Physiol Rev; 2024 Jan; 104(1):281-325. PubMed ID: 37712623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]